Every recall we track for VistaPharm LLC — 4 in all — plus the complaints and injury reports the public filed about them.
VistaPharm recalls Mycophenolate Mofetil oral suspension (200 mg/mL) due to bottle adaptor not fitting after reconstitution with water. Affected lots expire April 2025 or June 2025.
VistaPharm recalls 16oz Sucralfate Oral Suspension bottles due to Bacillus cereus contamination. This non-sterile product poses microbial safety risks. Consumers should check NDC 66689-305-16 and lot numbers for affected items.
VistaPharm recalls specific lots of Aminocaproic Acid Oral Solution due to high ethylene glycol content, a dangerous ingredient that can cause serious health issues.
VistaPharm recalls 414mL Sucr:alfate oral suspension (NDC 66689-305-16) due to drug assay results being out of specification. This affects prescription-only medication sold in the US.
